Marshall Wace North America’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1.07M | Buy |
+21,341
| New | +$1.07M | ﹤0.01% | 867 |
|
|
2019
Q4 | – | Sell |
-12,573
| Closed | -$657K | – | 1354 |
|
|
2019
Q3 | $657K | Sell |
12,573
-34,842
| -73% | -$1.82M | ﹤0.01% | 764 |
|
|
2019
Q2 | $2.29M | Buy |
47,415
+42,715
| +909% | +$2.06M | 0.01% | 534 |
|
|
2019
Q1 | $237K | Buy |
4,700
+3,359
| +250% | +$169K | ﹤0.01% | 947 |
|
|
2018
Q4 | $79K | Buy |
+1,341
| New | +$79K | ﹤0.01% | 1134 |
|
|
2018
Q1 | – | Sell |
-117,293
| Closed | -$5.45M | – | 1493 |
|
|
2017
Q4 | $5.45M | Buy |
+117,293
| New | +$5.45M | 0.03% | 560 |
|